Polymorphisms in specific genes, such as APOE, cystatin C (CST3), cholesterol 24-hydroxylase (CYP46) (8), and phosphatidylinositol-binding clathrin assembly protein gene (PICALM) (9), may be associated with the risk of development of MCI due to AD or AD itself. This evidence concerns the gene PICALM and Alzheimer disease.